Botanicals & women’s health
This article was originally published in The Tan Sheet
AHPA's "International Symposium on the Role of Botanicals in Women's Health" to be held at Rutgers University in New Brunswick, N.J. Feb. 16-18. Speakers will include U.S. Rep. Frank Pallone (D-N.J.), ODS Deputy Director Rebecca Costello, PhD, and Uwe Koetter, PhD, GlaxoSmithKline Consumer Healthcare director of new product research. For more information, contact AHPA Director of Education Natasha Hall at (301) 588-1171 ext. 106...
You may also be interested in...
A new analysis of the ADAURA study shows that Tagrisso’s disease-free survival benefits in early stage EGFRm NSCLC are replicated for brain metastases, a common complication with a poor prognosis. Filings and OS data await.
FDA has heard from some manufacturers that additional time is needed to meet all of the requirements, “especially during the COVID-19 pandemic.” Prior to the pandemic, agency announced enforcement discretion during 2020 for compliance by firms with more than $10m in annual sales.
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.